M. F. Sammons
Pfizer (United States)(US)PRX Research
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Asymmetric Synthesis and Catalysis, Synthetic Organic Chemistry Methods, Chemical Synthesis and Reactions, Diabetes Treatment and Management
Most-Cited Works
- → An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19(2021)1,854 cited
- → A Concise Formal Synthesis of Diazonamide A by the Stereoselective Construction of the C10 Quaternary Center(2010)77 cited
- → A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19(2024)61 cited
- → α-Arylation of 3-Aryloxindoles(2010)52 cited
- → Recent progress in the development of small-molecule glucagon receptor antagonists(2015)45 cited
- → The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus(2012)44 cited
- → The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus(2013)40 cited
- → Optimization of triazole-based TGR5 agonists towards orally available agents(2012)31 cited
- → Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1)(2018)30 cited
- → Identification of (R)-6-(1-(4-Cyano-3-methylphenyl)-5-cyclopentyl-4,5-dihydro-1H-pyrazol-3-yl)-2-methoxynicotinic Acid, a Highly Potent and Selective Nonsteroidal Mineralocorticoid Receptor Antagonist(2014)27 cited